Om

Jiangsu Hengrui Pharmaceuticals Co., Ltd. is a pharmaceutical company focused on the research, development, manufacturing, and commercialization of innovative medicines. Its current portfolio spans oncology, cardiovascular and metabolic diseases, autoimmune conditions, pain management, anti-infectives, and other therapeutic areas, reflecting a broad presence across major treatment categories. The company is also known for offering surgical drugs, contrast agents, and interventional imaging solutions, supporting both hospital-based care and specialty medicine use. Jiangsu Hengrui Pharmaceuticals Co., Ltd. operates as a research-driven drug developer with a diversified pipeline and a strong emphasis on high-quality products for unmet medical needs. In the financial markets, it is recognized as a leading Chinese pharmaceutical group with a significant role in innovative drug development and commercialization across domestic and international healthcare markets.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I JIANGSU HENGRUI PHARMACEUTICALS CO MED ENDAVU: Køb Jiangsu Hengrui Pharmaceuticals Co ($0BO) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Jiangsu Hengrui Pharmaceuticals Co, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.